And since the drug works outside of the brain, it isn't associated with addiction. Vertex expects this approval to be the beginning of a multibillion-dollar franchise, and it's clear this story ...
Shares of Vertex Pharmaceuticals (NASDAQ ... It prevents pain signals from reaching the brain. A lack of activity in the brain makes Journavx a non-addictive solution for all types of moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback